Brady Stephen R
- SEC CIK
- 0001606241
No open-market purchases or sales filed in the past year.
Current role at each company
- TPST Tempest Therapeutics, Inc.President and CEOas of Jan 6, 2025
- BCEL Atreca, Inc.Directoras of Jun 15, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Brady Stephen R as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TPST Tempest Therapeutics, Inc.
President and CEO1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 8, 2024 (view filing) | Jul 3 | 5 days | Brady Stephen RPresident and CEO | PPurchase | +35.0K | $2.11 | +$73.8K | +307.7%46.4K after |